Brann Mark R 4
4 · ACADIA PHARMACEUTICALS INC · Filed Mar 21, 2006
Insider Transaction Report
Form 4
Brann Mark R
DirectorPresident & CSO
Transactions
- Sale
Common Stock
2006-03-20$15.85/sh−5,000$79,250→ 342,756 total(indirect: By Trust) - Sale
Common Stock
2006-03-17$17.41/sh−12,500$217,625→ 363,756 total(indirect: By Trust) - Sale
Common Stock
2006-03-20$15.61/sh−16,000$249,760→ 347,756 total(indirect: By Trust) - Sale
Common Stock
2006-03-17$17.30/sh−1,500$25,950→ 376,256 total(indirect: By Trust)
Holdings
- 52,593
Common Stock
Footnotes (1)
- [F1]The sales reported in this Form 4 were effected pursuant to an existing sales plan established under Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.